Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Uterine Cervical Neoplasms × Axitinib × Clear all

Phase

Phase NA 1 Phase 1/2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Uterine Cervical Neoplasms 1 Colorectal Neoplasms 1 Carcinoma, Renal Cell 1

Interventions

Colposcopy 17 Methods 13 Early Intervention, Educational 11 Cisplatin 11 Human Papillomavirus DNA Tests 10 Brachytherapy 10 Educational Status 8 Biopsy 8 Radiotherapy 7 Papanicolaou Test 7 Magnetic Resonance Spectroscopy 7 Blood Specimen Collection 7 Vaginal Smears 6 Patient Navigation 6 Surveys and Questionnaires 5 Standard of Care 5 Mass Screening 5 Acetic Acid 5 Watchful Waiting 4 Therapeutics 4 Specimen Handling 4 Radiotherapy, Intensity-Modulated 4 Counseling 4 Sentinel Lymph Node Biopsy 3 Radiation 3 Psychiatric Rehabilitation 3 Palliative Care 3 Paclitaxel 3 Interviews as Topic 3 Drug Therapy 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03826589 2025-06-11

ALARICE

The University of Hong Kong

Phase NA Completed

Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡